Insider trading

Period: 120 months Stock: CUE Share of holding: 50% or more × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

14 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

14 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

14 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

14 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
14 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
14 decisions over 120 months Remove this filter
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

14 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
23 Mar 2023
Kiener Peter A Director
Sold at will
$30.59K 9,325 at 3.28
96.3%
Sold half or more
16 Nov 2021
Kiener Peter A Director
Sold, plan not stated
$24.53K 1,361 at 18.02
100%
Sold half or more
15 Nov 2021
Kiener Peter A Director
Sold, plan not stated
$337.16K 18,815 at 17.92
100%
Sold half or more
15 Mar 2021
Pienta Kenneth Chief Medical Officer
Sold, plan not stated
$196.27K 13,000 at 15.10
86.7%
Sold half or more
17 Feb 2021
Pienta Kenneth Chief Medical Officer
Sold, plan not stated
$64.35K 4,274 at 15.06
68.1%
Sold half or more
16 Feb 2021
Pienta Kenneth Chief Medical Officer
Sold, plan not stated
$242.42K 16,000 at 15.15
88.9%
Sold half or more
20 Jan 2021
Pienta Kenneth Chief Medical Officer
Bought
$40.98K 2,720 at 15.07
136%
First buy on file
31 Dec 2019
Sold, plan not stated
$141.39K 9,000 at 15.71
100%
Sold half or more
10 Jun 2019
Sandercock Colin SVP, General Counsel and Sec
Bought
$118.46K 14,938 at 7.93
747%
First buy on file
27 Dec 2018
Bought
$95.40K 20,000 at 4.77
66.7%
First buy on file
24 Dec 2018
Bought
$48.10K 10,000 at 4.81
50.0%
First buy on file
21 Dec 2018
MARLETT CHRISTOPHER A Director · indirect
Bought
$77.92K 17,200 at 4.53
50.2%
First buy on file
21 Dec 2018
Bought
$44.90K 10,000 at 4.49
100%
First buy on file
13 Dec 2018
MARLETT CHRISTOPHER A Director · indirect
Bought
$50.60K 10,000 at 5.06
93.2%
First buy on file
Showing 1–14 of 14.